Xiaojie Bian

1.3k citations
24 papers · 573 indexed · h-index 12
Topics
Cancer-related molecular mechanisms research (6 papers)Prostate Cancer Treatment and Research (5 papers)Bladder and Urothelial Cancer Treatments (3 papers)

In The Last Decade

Xiaojie Bian

21 papers receiving 573 citations

Peers

Xiaojie Bian
Comparison fields: 5 of 87
  • Molecular Biology 340
  • Cancer Research 270
  • Oncology 183
  • Pulmonary and Respiratory Medicine 104
  • Immunology 87
Replace Haoyue Hu with:
Haoyue Hu China
Takeshi Toyozumi Japan
Hui Jun Lim Singapore
Veronica Placencio-Hickok United States
Isaya Hashimoto Japan
Bei‐Ge Jiang China
Yufei Zhao China
Lifeng Wang China
Giorgia Guaitoli Italy
Gilbert Z. Murimwa United States
Xiaojie Bian relative to Haoyue Hu China Haoyue Hu's profile →
Citations per field
00.5×5.3×
Haoyue Hu · 1×
Citations per year

Countries citing papers authored by Xiaojie Bian

Since Specialization
Citations

This map shows the geographic impact of Xiaojie Bian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaojie Bian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaojie Bian more than expected).

Fields of papers citing papers by Xiaojie Bian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaojie Bian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaojie Bian. The network helps show where Xiaojie Bian may publish in the future.

Co-authorship network of co-authors of Xiaojie Bian

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaojie Bian. A scholar is included among the top collaborators of Xiaojie Bian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaojie Bian. Xiaojie Bian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 3
2 1
3 0
4 0
5 36
6 3
7 3
8 38
9 0
10 4
11 29
12 120
13 26
14 62
15
Increased expression of lncRNA ZEB1-AS1 in non-small cell lung cancer is associated with poor prognosis.
6
16 61
17 43
18 19
19 40
20 9

About Xiaojie Bian

Xiaojie Bian is a scholar working on Cancer Research, Modeling and Simulation and Oncology, having authored 24 papers that have together received 573 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (6 papers), Prostate Cancer Treatment and Research (5 papers) and Bladder and Urothelial Cancer Treatments (3 papers). The work is most often cited by research in Cancer Research (270 citations), Oncology (183 citations) and Molecular Biology (340 citations). Xiaojie Bian has collaborated with scholars based in China, United States and Finland. Frequent co-authors include Jianhua Wang, Leilei Du, Tianqi Wu, Mengfei Yao, Shancheng Ren, Yu‐Tian Xiao, Dingwei Ye, Min Jiang, Yijun Shen and Zeyi Liu. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Molecular Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026